---
figid: PMC4821380__ott-9-1899Fig1
figtitle: 'EGFR and IGF1R signaling pathways.Notes: Binding of extracellular ligands
  results in autophosphorylation of key tyrosine residues in the C-terminal domain
  of EGFR, which allows downstream proteins to bind through their Src homology 2 (SH2)
  domains'
organisms:
- NA
pmcid: PMC4821380
filename: ott-9-1899Fig1.jpg
figlink: /pmc/articles/PMC4821380/figure/f1-ott-9-1899/
number: F1
caption: 'EGFR and IGF1R signaling pathways.Notes: Binding of extracellular ligands
  results in autophosphorylation of key tyrosine residues in the C-terminal domain
  of EGFR, which allows downstream proteins to bind through their Src homology 2 (SH2)
  domains. This elicits the activation of downstream signaling cascades, including
  Ras/Raf/MEK/ERK, PI3K/Akt, JAK/STAT, and PLC, which ultimately drive tumor-cell
  proliferation, survival, and invasion. Growth factor-stimulated IGF1R or IR also
  induces the activation of the Akt- and ERK-signaling pathways. Akt phosphorylates
  and inactivates TSC2, leading to activation of the mTOR pathway. Activated Akt induces
  feedback by inhibiting FOXO transcription factors, thereby downregulating the expression
  of multiple receptor tyrosine kinases (RTKs) such as EGFR, IGF1R, and IR. mTOR-signaling
  activation exerts negative feedback by inhibiting IRS1, thereby attenuating PI3K/Akt
  activation from IGF1R or IR. Negative feedback by ERK also occurs through inhibition
  of Raf activity, and thus self-limits the activation of ERK signaling.'
papertitle: Advances in targeted and immunobased therapies for colorectal cancer in
  the genomic era.
reftext: Heng Fong Seow, et al. Onco Targets Ther. 2016;9:1899-1920.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9651401
figid_alias: PMC4821380__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC4821380__F1
ndex: 666d34f1-ded3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4821380__ott-9-1899Fig1.html
  '@type': Dataset
  description: 'EGFR and IGF1R signaling pathways.Notes: Binding of extracellular
    ligands results in autophosphorylation of key tyrosine residues in the C-terminal
    domain of EGFR, which allows downstream proteins to bind through their Src homology
    2 (SH2) domains. This elicits the activation of downstream signaling cascades,
    including Ras/Raf/MEK/ERK, PI3K/Akt, JAK/STAT, and PLC, which ultimately drive
    tumor-cell proliferation, survival, and invasion. Growth factor-stimulated IGF1R
    or IR also induces the activation of the Akt- and ERK-signaling pathways. Akt
    phosphorylates and inactivates TSC2, leading to activation of the mTOR pathway.
    Activated Akt induces feedback by inhibiting FOXO transcription factors, thereby
    downregulating the expression of multiple receptor tyrosine kinases (RTKs) such
    as EGFR, IGF1R, and IR. mTOR-signaling activation exerts negative feedback by
    inhibiting IRS1, thereby attenuating PI3K/Akt activation from IGF1R or IR. Negative
    feedback by ERK also occurs through inhibition of Raf activity, and thus self-limits
    the activation of ERK signaling.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - EGFR
  - IRS1
  - GRB2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - MLST8
  - MAP2K1
  - MAP2K2
  - RPTOR
  - TSC2
  - TSC1
  - CCL26
  - MAPK3
  - MAPK1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - EIF4EBP1
  - RPS6KB1
  - IGF1R
  - Egfr
  - drk
  - norpA
  - sl
  - Plc21C
  - hop
  - bsk
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Stat92E
  - Raf
  - Akt
  - Mtor
  - Tor
  - Lst8
  - raptor
  - Dsor1
  - Crtc
  - gig
  - Tsc1
  - rl
  - foxo
  - Thor
  - S6k
  - Tie
  - InR
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
